glp-1 agonists tirzepatide TrimRX Comparing Ozempic, Wegovy and Other

[4] Gastrointestinal side effects represent the most common adverse reactions to tirzepatide

As a result of this study, Dulaglutide had reduced MACE by 12% (HR 0.88, 95% Cl 0.79-0.99) and had produced a 15% relative risk reduction in the composite renal outcome

doi: 10.1002/ajh.25882 23 GrantW

Andersen, A., Knop, F

Note: Medicare Part D excludes weight loss coverage, but the new Medicare GLP-1 Bridge (July 2026) will cover Zepbound KwikPen at $50/month for qualifying beneficiaries

Its 39-amino-acid structure includes a C20 fatty di-acid moiety that extends half-life and enables weekly dosing in clinical research designs